AbbVie Inc
(BUE:ABBV)
ARS
21100
275 (1.32%)
Market Cap: 326.28 Til
Enterprise Value: 391.76 Til
PE Ratio: 63.33
PB Ratio: 53.42
GF Score: 74/100 Abbvie Inc at Evercore ISI HealthCONx Virtual Conference Transcript
Dec 02, 2021 / 05:10PM GMT
Joshua Elliott Schimmer
Evercore ISI Institutional Equities, Research Division - Senior MD & Equity Analyst
All right. Welcome, everyone. It's Josh Schimmer from the Evercore ISI Biotech team. We're very pleased to introduce from AbbVie, we have Mike Severino, Vice Chairman and President; we have Rob Michael, Chief Financial Officer; Jeff Stewart, Executive Vice President of Commercial Operations; and also joined by Carrie Strom, President of Global Allergan Aesthetics. So got the whole team and a lot of ground to cover.
Questions & Answers
Joshua Elliott Schimmer;Michael E. Severino
Evercore ISI Institutional Equities, Research Division - Senior MD & Equity Analyst;AbbVie Inc. - Vice
I'm going to start with the question really just to get it out of the way, why is everyone asking me about this AbbVie CF? Like it's the only topic that I get questions on. You may feel the same. Why is everyone still fixated on this? And what should we be looking for in the months or weeks or months ahead from the program?
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot